Dicerna Pharmaceuticals Logo

Email this page: News Release

Researchers Demonstrate Promise of Dicerna Investigational Therapy in Preclinical Model of Primary Hyperoxaluria Type 1 (PH1)

For security reasons, registration is required before you can use this feature.
* Indicates required field